baber/WOPTO huggingface dataset:
Patent AU-2020234957-A1 (AU)
Title: Signaling of adaptive picture size in video bitstream
Inventor: WENGER STEPHAN
IPC: H04N19/00
Filed: 2020-03-11
Abstract: A method of decoding a coded picture of a coded video sequence is performed by at least one processor and the method includes decoding, from a parameter set, a plurality of candidate decoded resolutions, selecting, through an index coded in a transient header structure applicable to a group of samples, a candidate decoded resolution among the plurality of candidate decoded resolutions, resampling a sample of the group of samples based on an output resolution and the selected candidate decoded resolution, and enabling prediction using the resampled sample.
Patent AU-2020244481-A1 (AU)
Title: Recombinant clostridium botulinum neurotoxins
Inventor: COSSINS AIMEE
IPC: C07K14/33
Filed: 2020-09-30
Abstract: The invention provides a nucleic acid sequence comprising a sequence of contiguous nucleotides, 
wherein said sequence of contiguous nucleotides has at least 90% sequence identity to the nucleic acid 
sequence of SEQ ID NO: 1, and wherein said sequence of contiguous nucleotides encodes a single
chain BoNT/El protein. The present invention also provides methods for producing soluble single-chain 
BoNT/E protein in an E. coli host cell, together with methods for producing soluble di-chain 10 BoNT/El 
protein.
Patent AU-2020255434-A1 (AU)
Title: Heat exchanger
Inventor: WATANABE MASATOSHI
IPC: F25B39/00
Filed: 2020-01-31
Abstract: A heat exchanger (5) comprises: a plurality of flat tubes (11); a header (12) to which the plurality of flat tubes are connected; an inflow plate (15) that separates a refrigerant inflow portion (14) and a lower circulation portion (16) inside the header; an upper-lower partition plate (18) that separates the lower circulation portion (16) and an upper circulation portion (17); a lower partition plate (161) that separates the lower circulation portion into an inside ascending path and an outside descending path, except for a lower communication path (163); and an upper partition plate (174) that partitions the upper circulation portion into an ascending path that is provided in at least a portion on the leeward side and a descending path that is provided at least on the windward side, except for an upper communication path (172). The inflow plate has, on the leeward and the inside, an ejection hole (151) for ejecting the refrigerant. The upper-lower partition plate has, on the leeward and the inside, a first passage port (18di) for allowing passage of the refrigerant, and at least on the windward outside, a second passage port (18uo) for allowing passage of the refrigerant.
Patent AU-2020277027-A1 (AU)
Title: Compounds for treating huntington's disease
Inventor: SYDORENKO NADIYA
IPC: A61K31/501
Filed: 2020-05-12
Abstract: The present description relates to compounds, forms, and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease. In particular, the present description relates to substituted monocyclic heteroaryl compounds of Formula (I), Formula (II), or Formula (III), forms and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease.
Patent AU-2020289695-A1 (AU)
Title: Monodisperse resorbable polyester polymer compositions
Inventor: FRANSSEN OKKE
IPC: A61L27/58
Filed: 2020-06-01
Abstract: Described herein are novel compositions comprising resorbable polyester polymers, such as poly-L-lactic acid particles, including novel compositions that function as neocollagenic dermal implants and that have unique physical properties as compared to compositions of similar composition previously known and/or used in the art. Also provided herein are novel systems comprising these compositions and related compositions and methods of using such compositions and systems, such as in aesthetic treatment.
Patent AU-2020291897-A1 (AU)
Title: Catheter assembly having a valve within a side port of a catheter adapter
Inventor: THIRUMOORTHY SANKARANARAYANAN
IPC: A61M39/02
Filed: 2020-05-21
Abstract: A catheter assembly (10) includes a catheter adapter (12). A body (14) of the catheter adapter (12) includes a distal end (18), a proximal end (20), and a lumen (22) extending through the distal end and the proximal end. A catheter (32) extends distally from the distal end of the body. The catheter adapter (12) includes a side port (16), which extends outwardly from the body. The catheter assembly may include a valve (40) disposed within the lumen (20). A valve (26) is disposed within a side port (16), the valve (26) including a channel (27) extending there through. The catheter includes a cannula (38+30) fixed within the side port (16) and disposed within the channel (27) of the valve. The cannula (38+30) includes an opening, and the valve (26) is configured to compress to expose the opening from within the valve.
Patent AU-2020294696-A1 (AU)
Title: Humanized antibody molecules to CD138 and uses thereof
Inventor: CHAGANTY BHARAT
IPC: A61P35/00
Filed: 2020-06-17
Abstract: Humanized antibody molecules that specifically bind to CD138 are disclosed. The humanized antibody molecules can be used to treat, prevent, and/or diagnose disorders, such as multiple myeloma.
Patent AU-2020315962-A1 (AU)
Title: Stable compositions of mRNA-loaded lipid nanoparticles and processes of making
Inventor: KARVE SHRIRANG
IPC: A61K31/7088
Filed: 2020-07-23
Abstract: The present invention provides an improved compositions and processes for preparing mRNA-loaded lipid nanoparticles (mRNA-LNPs). In some embodiments, the present invention provides mRNA-LNPs with exceptional stability and is particularly useful in cases where LNPs comprising low or no PEG-modified lipids are desired.
Patent AU-2020321177-A1 (AU)
Title: Organic semiconductive compound with an indol group, organic optoelectronic component with said type of compound and use of said type of compound
Inventor: COUTABLE LUDOVIC
IPC: H01L51/46
Filed: 2020-07-24
Abstract: The invention relates to a compound of the general formula I, to an optoelectronic component containing said type of compound, and to the use of such a compound in an optoelectronic component.
Patent AU-2020337720-A1 (AU)
Title: Imidazopyridine derivative and pharmaceutical composition comprising same as active ingredient
Inventor: LEE JAE WON
IPC: A61P1/16
Filed: 2020-08-31
Abstract: The present invention relates to an imidazopyridine derivative and a pharmaceutical composition comprising same as an active ingredient and, more particularly, to an imidazopyridine derivative that inhibits protein kinase activity and as such, can be used for preventing or treating cancer, neurodegenerative disease, non-alcoholic fatty liver disease, influenza, etc., and a pharmaceutical composition comprising same as an active ingredient.
Patent AU-2020341578-A1 (AU)
Title: Compositions containing adenosine triphosphate (ATP) and methods of use
Inventor: KOLB LARRY
IPC: C07H19/10
Filed: 2020-09-04
Abstract: The present invention provides a composition comprising adenosine or adenosine triphosphate (ATP) acting as an absorption enhancer when combined with a nutritional material(s) such as nutrients, protein, peptides, vitamins, phytochemicals, minerals, fatty acids, or amino acids or a drug. Methods of administering ATP or adenosine to improve the bioavailability of a nutritional material(s) such as nutrients, protein, peptides, vitamins, phytochemicals, minerals, fatty acids, or amino acids or a drug are described
Patent AU-2020357870-A1 (AU)
Title: Adjustable intraocular lenses and methods of post-operatively adjusting intraocular lenses
Inventor: SMILEY TERAH WHITING
IPC: G02C7/04
Filed: 2020-10-01
Abstract: Disclosed are adjustable intraocular lenses and methods of adjusting intraocular lenses post-operatively. In one embodiment, an adjustable intraocular lens can comprise an optic portion and a peripheral portion. The peripheral portion can comprise a composite material comprising an energy absorbing constituent and a plurality of expandable components. A base power of the optic portion can be configured to change in response to an external energy directed at the composite material.
Patent AU-2020371039-A1 (AU)
Title: Chimeric polypeptide for regulating immune cells
Inventor: SCHUMACHER ANTONIUS NICOLAAS MARIA
IPC: C12N5/0783
Filed: 2020-10-23
Abstract: The current invention relates to a chimeric polypeptide, a nucleic acid encoding such chimeric polypeptide, a cell comprising such chimeric polypeptide of nucleic acid, preferably a T cell, a CAR T cell, NK cell or a CAR NK cell, and method of treatment using such cell, polypeptide of nucleic acid in the treatment of cancer, in particular in immune cell therapy. The chimeric polypeptide according to the invention allows for the reversible and dose dependent control of T cell and NK cell function (cytokine release, cytotoxicity).
Patent AU-2020379171-A1 (AU)
Title: Methods of using IL-33 antagonists
Inventor: DAGHER RANIA
IPC: A61P11/00
Filed: 2020-11-03
Abstract: The present disclosure relates to an IL-33 antagonist for use in the prevention or treatment of abnormal epithelium physiology or EGFR-mediated diseases, and corresponding methods of prevention or treatment comprising administering an IL-33 antagonist to a patient in need thereof.
Patent AU-2020396055-A1 (AU)
Title: Antigen loading
Inventor: CLARK GEORGINA JANE
IPC: A61K39/395
Filed: 2020-12-04
Abstract: The invention relates to a method of antigen loading an antigen presenting cell or precursor thereof with a target antigen for presentation of the target antigen to a T cell, comprising contacting the antigen presenting cell or precursor thereof with a CD300f binding protein in the presence of the target antigen The invention also relates to compositions for antigen loading antigen presenting cells or precursors thereof, to immunoconjugates for antigen loading antigen presenting cells or precursors thereof, and use of antigen-loaded antigen presenting cells and immunoconjugates for promoting or increasing a T cell response to a target antigen in a subject.
Patent AU-2020401367-A1 (AU)
Title: 3-D reconstruction using augmented reality frameworks
Inventor: UPENDRAN MANISH
IPC: G06Q10/06
Filed: 2020-12-11
Abstract: System and method are provided for scaling a 3-D representation of a building structure. The method includes obtaining images of the building structure, including non-camera anchors. The method also includes identifying reference poses for images based on the non- camera anchors. The method also includes obtaining world map data including real-world poses for the images. The method also includes selecting candidate poses from the real-world poses based on corresponding reference poses. The method also includes calculating a scaling factor for a 3-D representation of the building structure based on correlating the reference poses with the selected candidate poses. Some implementations use structure from motion techniques or LiDAR, in addition to augmented reality frameworks, for scaling the 3-D representations of the building structure. In some implementations, the world map data includes environmental data, such as illumination data, and the method includes generating or displaying the 3-D representation.
Patent AU-2020402505-A1 (AU)
Title: Elastic diaper element
Inventor: BALDAUF GEORG
IPC: A61F13/15
Filed: 2020-08-27
Abstract: The invention relates to an elastic diaper element that comprises an elastic layer (1) and at least one layer (2) made of a non-woven. The elastic element has connection portions (5) between the elastic layer (1) and the non-woven layer (2). The connection portions (5) extend in a preferred direction. The non-woven layer (2) is corrugated when the diaper element is in the unstretched condition in order to provide portions (6) as a reserve allowing stretching. According to the invention, the connection portions (5) have discontinuities (10) along their extent.
Patent AU-2020403209-A1 (AU)
Title: Application development involving instant prototyping
Inventor: DUGGAL SACHIN DEV
IPC: G06F8/36
Filed: 2020-12-12
Abstract: A system for developing software provides a graphical user interface on a display of a client device, the graphical user interface displaying features from a library of features for a custom software application, implements simulations of a plurality of the features available for demonstration through the graphical user interface, stores blocks of source code for each feature in a source code repository wherein the blocks are adapted to provide an actual application when compiled by developers, receives from the client device, by a server running a software building component, one or more selected features for the software application, automatically integrates, by the software building component, the one or more selected features to generate an integrated feature set based on attributes of each of the selected features and an inter-feature rules set, and generates an interactive visualization of a navigable prototype of the software application based on the integrated feature set.
Patent AU-2020403452-A1 (AU)
Title: Digital payment system
Inventor: DAVENPORT STUART
IPC: G06Q20/16
Filed: 2020-12-08
Abstract: A method of processing a transaction in a digital network uses data strings to identify parties, the data strings having a prescribed format comprising first, second and third data fields and a checksum, whereby the value of first data field identifies an accrediting entity; the value of the second data field identifies an issuing entity acting as a settlement proxy for a customer; the value of the third data field identifies a customer; and the value of the checksum establishes the integrity of the data string. The method comprises the steps of: providing a primary data string to a customer; assigning an address space within the third data field for use by a further party acting with the authority of the customer, such that (i) all third data values within the assigned address space are available for use in creating valid data strings and (ii) valid data strings having third data values which lie within the designated address space are subordinate data strings to the primary data string within a data hierarchy; establishing constraints subject to which transactions using a given subordinate data string may be conducted and identifying to the accrediting agency, by reference to a range of values lying within the assigned address space, a location within the network of those transaction constraints; requesting a token having the prescribed data format and a valid checksum from the accrediting entity by submitting a token request that includes the given subordinate data string; parsing the token request to identify the given subordinate data string and the location of the transaction constraints; requesting the transaction constraints from the location and storing them at the accrediting entity.
Patent AU-2020408011-A1 (AU)
Title: Bed lifting mechanism
Inventor: VOS JULIAN
IPC: A61G7/012
Filed: 2020-12-18
Abstract: The present invention relates to the field of lifting mechanisms for beds, and beds incorporating such lifting mechanisms. A lifting mechanism for a bed comprises a leg connecting a foot to a frame for supporting a mattress, the frame defining a support plane; an actuator; a drive linkage mechanism comprising a drive input link pivotally connected to the frame about a first pivot axis and a drive output link pivotally connected to the frame about a second pivot axis; and a leg linkage mechanism comprising a leg input link and a leg output link, the leg input link being pivotally connected to the frame about the second pivot axis and being coupled to the drive output link, and the leg output link being pivotally connected to the frame about a third pivot axis, and wherein a length of the leg input link is shorter than a length of the drive output link.
Patent AU-2020413997-A1 (AU)
Title: Pyridazinyl-thiazolecarboxamide compound
Inventor: WATANABE HIDEYUKI
IPC: C07D498/10
Filed: 2020-12-24
Abstract: Provided is a compound that is useful as an active ingredient of a medicinal composition for treating cancer related to immunocyte activation or cancer resistant to anti-PD-1 antibody/anti-PD-L1 antibody therapy. The present inventors studied compounds being useful as an active ingredient of a medicinal composition for treating cancer related to immunocyte activation or cancer resistant to anti-PD-1 antibody/anti-PD-L1 antibody therapy and confirmed that a pyridazinyl thiazolecarboxamide compound has an effect of inhibiting DGKζ (DGKzeta) to thereby complete the present invention. The pyridazinyl thiazolecarboxamide compound of the present invention has an effect of inhibiting DGKζ and is usable as a therapeutic agent for cancer related to immunocyte activation or cancer resistant to anti-PD-1 antibody/anti-PD-L1 antibody therapy.
Patent AU-2020484083-A1 (AU)
Title: Photovoltaic system, power supply system, and control method
Inventor: ZHANG YANZHONG
IPC: H02J3/38
Filed: 2020-12-31
Abstract: The present application discloses a photovoltaic system, a power supply system, and a control method. A first inverter has a first input end connected to a second end of a direct-current positive bus, and a second input end connected to a second end of a neutral bus; a second inverter has a first input end connected to the second end of the neutral bus, and a second input end connected to a second end of a direct-current negative bus; and a controller is used for controlling, during startup and shutdown, a voltage of the direct-current positive bus to the ground, a voltage of the direct-current negative bus to the ground, and a voltage of the neutral bus to the ground to be less than or equal to a preset voltage threshold, so as to ensure personal and device safety. During startup, shutdown, and working of the photovoltaic system, the controller controls the startup and shutdown sequence of each device in the photovoltaic system, and ensures that the voltages of three direct-current buses to the ground cannot exceed the requirements of a safety voltage, so as to ensure the personal and device safety. If overvoltage occurs during working of the photovoltaic system, the photovoltaic system needs to be protected in time to avoid the expansion of a fault range.
Patent WO-2021151167-A1 (WO)
Title: Wearable apparatus for the treatment of mastitis
Inventor: TAHGHIGHI JAFARZADEH MASOUD
IPC: A61N5/06
Filed: 2021-02-01
Abstract: Wearable apparatus for the treatment of mastitis, the apparatus comprising a mammary gland wearable comprising an array of light source elements thereon emitting electromagnetic radiation having a wavelength in the range of 380 – 1050 nm, a power supply coupled to the array of light source elements, the wearable configured to be worn against a mammary gland in use wherein the array of light source elements emit the radiation which penetrates epidermis of the mammary gland for the treatment of mastitis.
Patent WO-2022077049-A1 (WO)
Inventor: MERVIN KYLE ANDREW
IPC: A61B6/08
Filed: 2021-09-15
Abstract: L'invention concerne un dispositif de focalisation pour l'utilisation de rayons X et de rayons gamma en radiothérapie, le dispositif comprenant un élément de forme tronconique radio-opaque ayant une première extrémité et une deuxième extrémité. L'élément comprend un réseau de trajets de faisceaux radio-transparents qui s'étendent de la première extrémité à la deuxième extrémité, chacun des trajets de faisceaux ayant une ouverture d'entrée à la première extrémité et une ouverture de sortie à la deuxième extrémité. Les rayons source passent à travers l'ouverture d'entrée dans le trajet de faisceau, le trajet de faisceau émettant un faisceau depuis l'ouverture de sortie lorsque les rayons source sont alignés avec l'axe longitudinal du trajet de faisceau ou ont un angle de déviation prédéterminé par rapport à l'axe longitudinal des trajets de faisceau. Chacun des axes longitudinaux des trajets de faisceau est incliné par rapport à l'axe longitudinal de l'élément pour une convergence vers un point focal ou des points multiples.
Patent AU-2021200050-A1 (AU)
Title: Isolated T cell receptors and methods for use therefor
Inventor: ZARLING ANGELA
IPC: A61P35/00
Filed: 2021-01-06
Abstract: Provided are isolated TCRs, TCR-like molecules, and portions thereof that bind to 
phosphopeptide-HLA-A2 complexes. The isolated TCRs, TCR-like molecules, or portions are 
optionally soluble TCRs, TCR-like molecules, or portions. Also provided are isolated nucleic acids 
encoding the disclosed TCRs, TCR-like molecules, or portions; host cells that contain the disclosed 
TCRs, TCR-like molecules, or portions; pharmaceutical compositions that include the disclosed 
TCRs, TCR-like molecules, portions, nucleic acids, and/or T cells; kits; and methods of using the 
same.
Patent AU-2021200180-A1 (AU)
Title: Golf club alignment devices
Inventor: WEDDUP SCOTT
IPC: A63B69/36
Filed: 2021-01-13
Abstract: Embodiments of the present disclosure provide a golf alignment device configured to 
be used with a golf club. The golf club alignment device includes a mounting member 
extending at an angle from a crown surface of a golf club head. The mounting member 
may include a reflective surface to assist a player view a pin and align the golf club 
with respect to the pin without looking in a direction of the pin prior to making a putting 
action. Further, the pin (or flagship) may be a centre of a hole. The reflective surface 
may include a mirror for enabling the player to see the pin and accordingly align the 
golf club. The golf club alignment device further comprises an adjustment clasp for 
enabling the player to adjust the angle of the mounting member to suit a stance of the 
player.
4/4 
FIGURE 4A 402 
400A 104 
"404 
408 
406 410 
FIGURE 4B 406 408 
400B 
412 
1402 
404
Patent AU-2021201640-A1 (AU)
Title: Methods for detecting and/or measuring anti-drug antibodies, in particular treatment-emergent anti-drug antibodies
Inventor: SNOECK VEERLE
IPC: G01N33/531
Filed: 2021-03-16
Abstract: Method for detecting and/or measuring anti-drug antibodies against a protein, polypeptide or 
other compound or molecule that comprises at least one immunoglobulin variable domain 
with an exposed C-terminal region in a sample, said method, comprising at least the steps of: 
5 a) contacting said sample with a capturing agent that is immobilized on a support, wherein 
said capturing agent is or essentially consists of said protein, polypeptide or other compound 
or molecule, under conditions such that any anti-drug antibodies against said protein, 
polypeptide or other compound or molecule can bind to said capturing agent; b) (optionally) 
removing any components or constituents present in said sample that do not bind to the 
10 capturing agent; c) detecting or measuring any anti-drug antibodies that have bound to the 
capturing agent, by contacting the complex of the capturing agent and any captured anti-drug 
antibodies with a detection agent, under conditions such that said detection agent can bind to 
(the complex of the capturing agent and) any captured anti-drug antibodies, wherein either: x) 
said capturing agent is or essentially consists of: (i) said protein, polypeptide or other 
15 compound or molecule (immobilized on the solid support); and (ii) 1-5 amino acid residues 
that are linked to the exposed C-terminal end of the immunoglobulin variable domain with the 
exposed C-terminal region that is comprised within the protein, polypeptide or other 
compound or molecule; y) said detection agent is or essentially consists of: (i) said protein, 
polypeptide or other compound or molecule; (ii) a detectable tag or label bound to said 
20 protein, polypeptide or other compound or molecule (either directly or via a suitable linker) 
and (iii) 1-5 amino acid residues that are linked to the exposed C-terminal end of the 
immunoglobulin variable domain with the exposed C-terminal region that is comprised within 
the protein, polypeptide or other compound or molecule.